These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10102436)

  • 21. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in treatment of neurocysticercosis.
    Agarwal AK; Dudeja RK; Chandra S
    J Assoc Physicians India; 1994 Jan; 42(1):88. PubMed ID: 7836272
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China.
    Wu W; Jia F; Wang W; Huang Y; Huang Y
    Parasitol Res; 2013 Aug; 112(8):2879-90. PubMed ID: 23695946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK; Wang KC; Paek SH; Hong KS; Cho BK
    Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
    Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst.
    Bustos JA; Pretell EJ; Llanos-Zavalaga F; Gilman RH; Del Brutto OH; Garcia HH;
    Clin Neurol Neurosurg; 2006 Feb; 108(2):193-4. PubMed ID: 16412842
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
    Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.
    Sotelo J; del Brutto OH; Penagos P; Escobedo F; Torres B; Rodriguez-Carbajal J; Rubio-Donnadieu F
    J Neurol; 1990 Apr; 237(2):69-72. PubMed ID: 2192018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P; Dayal D; Khandelwal N
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of the single-day praziquantel therapy for neurocysticercosis.
    López-Gómez M; Castro N; Jung H; Sotelo J; Corona T
    Neurology; 2001 Nov; 57(10):1929-30. PubMed ID: 11723297
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albendazole therapy for neurocysticercosis.
    Escobedo F; Penagos P; Rodriguez J; Sotelo J
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short course of albendazole therapy for neurocysticercosis.
    Sotelo J; Penagos P; Escobedo F; Del Brutto OH
    Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of neurocysticercosis with a two week course of albendazole.
    Chotmongkol V
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):396-8. PubMed ID: 8266251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cysticercosis of the cerebellopontine angle: treatment with single-dose praziquantel].
    del Brutto OH
    Rev Neurol; 2000 Nov 1-15; 31(9):835-7. PubMed ID: 11127085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.